EAN 2017

1:38
The neuropathology and genetics of ALS and FTD
Manuela Neumann
3:07
ASL MRI as an early biomarker for Alzheimer’s disease
M. Hale Alpsan Gökmen
3:31
ALS and frontotemporal dementia: on a continuum or part of a spectrum of disorders?
Manuela Neumann
4:31
Challenges of managing the neuropsychiatric symptoms of Alzheimer’s and vascular dementia
Pasquale Calabrese
3:11
A novel biomarker of Alzheimer’s disease progression: LTP-like cortical plasticity
Francesco Di Lorenzo
2:41
Angiotensin receptor blockers on cognitive function in Alzheimer’s disease
Fabricio Ferreira De Oliveira
1:47
APOE haplotypes, ACE insertion/deletion polymorphism and neuropsychiatric symptoms in Alzheimer’s
Fabricio Ferreira De Oliveira
1:02
Investigating physical activity and Alzheimer’s disease
Kristian Steen Frederiksen
1:24
Challenges with comorbidities and dementia
Dorota Religa
1:17
Pioglitazone for the treatment of Alzheimer’s disease
Daniela Galimberti
0:49
Outcome measures and comorbidities in dementia
Dorota Religa
2:03
Strategies for the prevention of vascular cognitive impairment
Leonardo Pantoni
1:06
Cerebrospinal fluid (CSF) and imaging biomarkers for the differential diagnosis of dementia
Philip Scheltens
3:40
Dementia, it’s not only Alzheimer’s disease
Antonio Federico
1:15
Risk factors for developing dementia
Daniela Galimberti
4:10
Atypical parkinsonian disorders
Kailash P. Bhatia
The content of VJDementia is intended for healthcare professionals